0001505148-20-000016.txt : 20201113 0001505148-20-000016.hdr.sgml : 20201113 20201113153932 ACCESSION NUMBER: 0001505148-20-000016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201111 FILED AS OF DATE: 20201113 DATE AS OF CHANGE: 20201113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CONNICK HARRY F SR CENTRAL INDEX KEY: 0001263356 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13738 FILM NUMBER: 201311203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PSYCHEMEDICS CORP CENTRAL INDEX KEY: 0000806517 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 581701987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 125 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-206-8220 MAIL ADDRESS: STREET 1: 125 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2020-11-11 0000806517 PSYCHEMEDICS CORP PMD 0001263356 CONNICK HARRY F SR C/O PSYCHEMEDICS CORPORATION 289 GREAT ROAD, SUITE 200 ACTON MA 01720 1 0 0 0 Common Stock, $.005 Par Value 2020-11-11 4 A 0 20000 0 A 79112 D Stock Option (Right to Buy) 4.07 2020-11-11 4 A 0 2000 0 A 2030-11-11 Common Stock, $.005 Par Value 2000 2000 D Represents restricted stock units that are to be settled solely in shares of Common Stock. The units vest with respect to 50% of the shares on November 11, 2021 and with respect to the remaining 50% on November 11, 2022, so long as the recipient continues as a director of the Issuer through each such respective vesting date. The option becomes exercisable with respect to 50% of the shares on November 11, 2021 and with respect to the remaining 50% on November 11, 2022, so long as the recipient continues as a director of the Issuer through each such respective vesting date. Patrick J. Kinney, Jr. as attorney-in-fact for Harry F. Connick 2020-11-13